4 completed, 2 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Unknown 2 |
Follow Malignant Neoplasm of Stomach: new trials by email Literature Review of Malignant Neoplasm of Stomach trials Research Report on Malignant Neoplasm of Stomach
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer D2 radical gastrectomy, SOX neoadjuvant or postoperative chemotherapy, Hyperthermic intraperitoneal chemotherapy (HIPEC) - Malignant Neoplasm of Stomach | Phase 2 | Unknown | Wuhan University | 100 | 2020-04-01 | 2020-04-14 |
| Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer Hyperthermic intraperitoneal chemotherapy (HIPEC), D2 radical gastrectomy, SOX postoperative chemotherapy - Malignant Neoplasm of Stomach | Phase 2 | Completed | Wuhan University | 100 | 2015-08-01 | 2020-03-24 |
| Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma Cisplatin, 5-fluorouracil or Capecitabine, Trastuzumab - Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 172 | 2015-07-15 | 2025-07-31 |
| Early Recovery After Gastric Cancer Surgery Early recovery - Fasting, Malignant Neoplasm of Stomach | Phase 2 | Unknown | Ajou University School of Medicine | 109 | 2012-07-01 | 2012-07-20 |
| MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma Oxaliplatin, Folinic Acid, 5-fluoro-uracil - Malignant Neoplasm of Esophagus, Malignant Neoplasm of Stomach | Phase 2 | Completed | UNICANCER | 162 | 2011-01-01 | 2020-11-17 |
| Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE Capecitabine/Cisplatin + Sorafenib, Capecitabine/Cisplatin - Malignant Neoplasm of Stomach, Effects of Chemotherapy | Phase 2 | Completed | Asan Medical Center | 195 | 2010-08-01 | 2020-01-07 |
Stomach Neoplasms (6) · Adenocarcinoma (1) · Esophageal Neoplasms (1) · Fasting (1)
Digestive System Diseases (6) · Digestive System Neoplasms (6) · Gastrointestinal Diseases (6) · Gastrointestinal Neoplasms (6) · Neoplasms (6) · Neoplasms by Site (6) · Stomach Diseases (6) · Behavior (1) · Carcinoma (1) · Esophageal Diseases (1) · Feeding Behavior (1) · Head and Neck Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Capecitabine (2) · Cisplatin (2) · Hyperthermic Intraperitoneal Chemotherapy (2) · Drug Therapy (1) · Fluorouracil (1) · Gastrectomy (1) · Leucovorin (1) · Oxaliplatin (1) · Panitumumab (1) · Sorafenib (1) · Surgical Procedures, Operative (1) · Trastuzumab (1) · pertuzumab (1) · rilotumumab (1)
Wuhan University (2) · Ajou University School of Medicine (1) · Asan Medical Center (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · UNICANCER (1)
South Korea (3) · China (2) · France (2) · Belgium (1) · Estonia (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · Portugal (1) · Singapore (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
PMID 27486629, PMID 31126258, PMID 31930513
2009 (1), 2014 (1)